Isorhamnetin-3-O-beta-D-Glucoside

Isorhamnetin-3-O-beta-D-Glucoside
Product Name Isorhamnetin-3-O-beta-D-Glucoside
CAS No.: 5041-82-7
Catalog No.: CFN99757
Molecular Formula: C22H22O12
Molecular Weight: 478.40 g/mol
Purity: >=98%
Type of Compound: Flavonoids
Physical Desc.: Yellow powder
Targets: IL Receptor
Source: The herbs of Typha orientalis Presl.
Solvent: DMSO, Pyridine, Methanol, Ethanol, etc.
Price: $218/10mg
Isorhamnetine-3-O-rutinoside inhibits the activity of alpha-glucosidase from rat intestine; it exhibits a potent rat lens aldose reductase (RLAR) inhibition in vitro, its IC(50) being 1.4 microM and has inhibitory effects of sorbitol accumulation, suggests that it is a leading compound for further study as a new drug for the prevention and/or treatment of diabetes and its complications.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • Natural Product Communications2020, doi: 10.1177.
  • Eur J Pharmacol.2018, 832:96-103
  • Institute of Food Science & Technology2021, 56(11).
  • Chemistry of Plant Materials.2019, 215-222
  • Phytomedicine.2022, 100:154058.
  • Horticulturae2022, 8(10), 975.
  • Life (Basel).2023, 13(2):457.
  • Molecules.2023, 28(8):3474.
  • J Ethnopharmacol.2023, 313:116534.
  • VNU Journal of Science2023, No. 20.
  • Isorhamnetin 3-glucuronide

    Catalog No: CFN90568
    CAS No: 36687-76-0
    Price: Inquiry(manager@chemfaces.com)
    Isorhamnetin-3-O-neohespeidoside

    Catalog No: CFN99744
    CAS No: 55033-90-4
    Price: $60/20mg
    Narcissoside

    Catalog No: CFN99773
    CAS No: 604-80-8
    Price: $70/20mg
    Isorhamnetin-3-O-glucosyl-(1->4)-O-rhamnoside

    Catalog No: CFN95723
    CAS No: 1135753-17-1
    Price: $318/5mg
    Astragaloside

    Catalog No: CFN99170
    CAS No: 17429-69-5
    Price: Inquiry(manager@chemfaces.com)
    Isorhamnetin 3,5-O-diglucoside

    Catalog No: CFN95488
    CAS No: 2035413-03-5
    Price: $318/5mg
    Typhaneoside

    Catalog No: CFN98146
    CAS No: 104472-68-6
    Price: $100/20mg
    Ombuin 3-glucoside

    Catalog No: CFN96156
    CAS No: 158642-42-3
    Price: $413/5mg
    Polygalin C

    Catalog No: CFN95118
    CAS No: 934768-05-5
    Price: $288/5mg
    Polygalin J

    Catalog No: CFN95175
    CAS No: N/A
    Price: $318/5mg
    Biol Pharm Bull. 2005 May;28(5):916-8.
    Inhibitory effects of isorhamnetin-3-O-beta-D-glucoside from Salicornia herbacea on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.[Pubmed: 15863906]
    The inhibitory effects of compounds from Salicornia herbacea (Chenopodiaceae) on rat lens aldose reductase (RLAR) and sorbitol accumulation in streptozotocin-induced diabetic rat tissues were investigated.
    METHODS AND RESULTS:
    The various fractions from the MeOH extract of S. herbacea were tested for their effects on RLAR in vitro. Among them, the EtOAc fraction was found to exhibit a potent RLAR inhibition (IC(50)=0.75 microg/ml), from which an active principle as a potent AR inhibitor was isolated and its chemical structure was elucidated as Isorhamnetin-3-O-beta-D-Glucoside (1) by spectral analysis. Compound 1 exhibited a potent RLAR inhibition in vitro, its IC(50) being 1.4 microM. Compound 1, when administered orally at 25 mg/kg in streptozotocin (STZ)-induced diabetic rats, caused not only a significant inhibition of serum glucose concentration but also sorbitol accumulation in the lenses, red blood cells (RBC), and sciatic nerves.
    CONCLUSIONS:
    These results indicate that compound 1 from S. herbacea is a leading compound for further study as a new drug for the prevention and/or treatment of diabetes and its complications.
    Acta Pol Pharm. 2012 Mar-Apr;69(2):171-7.
    A review of chemistry and biological activities of the genus Aerva--a desert plant.[Pubmed: 22568031]
    There are approximately 28 species of Aerva genus, but only a few species are medicinal of which A. persica, A. lanata and A. javanica are of great value.
    METHODS AND RESULTS:
    A number of flavonol glycosides (e.g., aervanone, kaempferol-3-galactoside, Isorhamnetin-3-O-beta-D-Glucoside) have been reported from Aerva persica as major phytoconstituents and the minor constituents are β-cyanins (glycine betaine and trigonelline), sterols and carbohydrates. This plant is used as medicinal herb in several traditional systems of medicine all over the world, like diuretic, demulcent, purgative, emetic and tinder. Aerva plants are used to cure ulcer, lithiasis, dropsical affections, eye affection, toothache, headache, in disorders of abdomen and inflammation of internal organs.
    CONCLUSIONS:
    Roots and flowers are reported to possess hypoglycemic, antioxidant, anthelmintic, analgesic, antimalarial, antivenin activities and medicinal properties against rheumatism and kidney troubles.
    J Nat Med. 2008 Jul;62(3):349-53.
    Antioxidant constituents in the dayflower (Commelina communis L.) and their alpha-glucosidase-inhibitory activity.[Pubmed: 18409066 ]
    The dayflower, Commelina communis L., contains 1-deoxynojirimycin (DNJ) and (2R,3R,4R,5R)2,5-bis(hydroxymethyl)-3,4-dihydroxypyrrolidine (DMDP), potent alpha-glucosidase inhibitors. The extracts and powder of this herb are important food materials for prophylaxis against type 2 diabetes.
    METHODS AND RESULTS:
    Eleven flavonoid glycosides as antioxidants, isoquercitrin, isorhamnetin-3-O-rutinoside, Isorhamnetin-3-O-beta-D-Glucoside, glucoluteolin, chrysoriol-7-O-beta-D-glucoside, orientin, vitexin, isoorientin, isovitexin, swertisin, and flavocommelin, were identified from the aerial parts of C. communis. Their antioxidant activities were measured using in vitro assays employing the 1,1-diphenyl-2-picrylhydrazyl radical- and superoxide radical-scavenging assays.
    CONCLUSIONS:
    The results showed that glucoluteolin, orientin, isoorientin, and isoquercitrin are the predominant antioxidants in this herb. Moreover, isoquercitrin, isorhamnetine-3-O-rutinoside, vitexin, and swertisin inhibited the activity of alpha-glucosidase from rat intestine.
    Z Naturforsch C. 2012 May-Jun;67(5-6):266-74.
    Isolation of new cytotoxic metabolites from Cleome droserifolia growing in Egypt.[Pubmed: 22888531]
    The sulforhodamine B (SRB) assay was used to assess the cytotoxicity of the aqueous (AqEx) and ethanolic (AlEx) extracts, respectively, of the aerial parts of Cleome droserifolia (Forssk.) Del. against two human cancer cell lines, breast (MCF7) and colon (HCT116) adenocarcinoma.
    METHODS AND RESULTS:
    AqEx exhibited higher cytotoxic activity, thus its four subfractions, namely n-hexane (HxFr), chloroform (ClFr), ethyl acetate (EtFr), and n-butanol (BuFr) fractions, were also tested. Purification of the more active ClFr and EtFr yielded nine compounds. Six terpenoids, guai-7(11),8-diene (C1), 1-hydroxy-guai-3,10(14)-diene (C2), 18-hydroxydollabela-8(17)-ene (C3), (24E)-stigmasta-5,8-dien-3beta-ol (C4), teucladiol [1alpha,5beta-guai-10(14)-ene-4beta,6beta-diol] (C5), and buchariol (4,10-epoxy-6a-hydroxyguaiane) (C6), were isolated from ClFr and three flavonol glycosides, Isorhamnetin-3-O-beta-D-Glucoside (F1), quercetin-3'-methoxy-3-O-(4"-acetylrhamnoside)-7-O-alpha-rhamnoside (F2), and kaempferol-4'-methoxy-3,7-O-dirhamnoside (F3), were isolated from EtFr. Compounds C3 and F2 are new in nature. The isolated compounds were identified using various spectroscopic methods (UV, IR, 1H NMR, 13C NMR, HMQC, HMBC, and COSY).
    CONCLUSIONS:
    Compounds C1, C3, F2, and F3 showed significant cytotoxic activities against the two tested cell lines comparable to those of the anticancer drug doxorubicin. The new compound C3 was the most active as it had the lowest IC50 values, (1.9 +/- 0.08) and (1.6 +/- 0.09) microg/ml corresponding to 6.5 and 5.4 microM, against MCF7 and HCT116 cells, respectively.
    Molecules. 2012 Apr 17;17(4):4595-603.
    A new isorhamnetin glycoside and other phenolic compounds from Callianthemum taipaicum.[Pubmed: 22510608]
    A new flavonol glycoside together with five known phenolic compounds were isolated from the whole herb of Callianthemum taipaicum.
    METHODS AND RESULTS:
    The compounds were identified as isorhamnetin-3-O-α-L-arabinoside-7-O-β-D-glucoside (1), Isorhamnetin-3-O-beta-D-Glucoside(2), dibutyl phthalate (3), (+)-1-hydroxylpinoresinol-4'-β-D-glucoside (4), pinoresinol-4'-O-β-D-glucoside (5) and 2-phenylethyl-β-primeveroside (6). Compound 1 was identified as a new flavonol glycoside. The compound 6 was isolated for the first time as natural product. All compounds were isolated for the first time from the Callianthemum genus. Furthermore, the 2D-NMR data of the four known compounds 2-5 are given for the first time in this paper.
    CONCLUSIONS:
    All the structures were identified on the basis of detailed spectral analysis. The compounds 1 and 4 exhibited certain antifungal activity.
    9-O-Acetyl-fargesol

    Catalog No: CFN95031
    CAS No: 449172-61-6
    Price: $413/5mg
    Pueroside B

    Catalog No: CFN95141
    CAS No: 100692-54-4
    Price: $288/10mg
    New compound 3

    Catalog No: CFN95184
    CAS No: N/A
    Price: $368/5mg
    Pieceid-2''-O-gallate

    Catalog No: CFN95226
    CAS No: 64898-03-9
    Price: $318/10mg
    3-O-Methylellagic acid 3'-O-alpha-rhamnopyranoside

    Catalog No: CFN95375
    CAS No: 352280-34-3
    Price: $413/5mg
    Dihydrophaseic acid 4'-O-beta-D-glucopyranoside

    Catalog No: CFN95393
    CAS No: 78914-56-4
    Price: $318/5mg
    Oxytroflavoside A

    Catalog No: CFN95463
    CAS No: 1391144-80-1
    Price: $318/5mg
    New compound 16

    Catalog No: CFN95465
    CAS No: N/A
    Price: $413/5mg
    Ganoweberianic acid E

    Catalog No: CFN95504
    CAS No: 1309931-90-5
    Price: $413/5mg
    8-epi-Confertin

    Catalog No: CFN95509
    CAS No: 110115-60-1
    Price: $318/5mg